![](https://testing.innoplexus.com/wp-content/plugins/relevant/images/no_preview.jpg)
Ontosight® – Biweekly NewsletterJune 17th – June 30th, 2024 –Read More
Ontosight® – Biweekly NewsletterJune 17th – June 30th, 2024 –Read More
May 24
Apr 24
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreHoboken, New Jersey: Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced today the publication of a new study examining consumer perceptions about drug prices, transparency, and other issues related to the pharmaceutical industry. This survey of over 1,000 American consumers was commissioned by Innoplexus and conducted by Haven Insights, a leading research firm that works with organizations such as Stanford, MIT, and P&G.
Top insights from the study include:
“We commissioned this survey to analyze deeply the priorities, concerns, and hopes that shape the public’s perception of pharmaceutical companies,” said Gunjan Bhardwaj, CEO of Innoplexus, “We hope that these insights can contribute to necessary reforms and drive innovations within the industry to build better relationships between pharma companies and patients.”
Get the details:
About Innoplexus
Innoplexus AG offers Data-as-a-Service and Continuous Analytics-as-a-Service products and solutions that help organizations move towards continuous decision-making. By leveraging cutting-edge Artificial Intelligence and Deep Learning technologies, Innoplexus helps organizations generate insights from structured and unstructured private and public data. Founded in 2011, INNOPLEXUS AG is headquartered in Eschborn, Germany with offices in Pune, India, and Hoboken, USA. Learn more at https://www.innoplexus.com.
For questions or comment contact our agency of record:
Andrew Sears, Front Lines Media | e: andrew@frontlines.io c: 949-230-2651
Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…
Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF…
During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the…
Frankfurt, Germany; 14 March 2024 Partex Group, a pioneer in AI-driven drug discovery, today announces a collaboration with global pharmaceutical…
January 02, 2024 – Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health…
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…